Piracetam for Treatment of Cocaine Addiction - 3

University of Pennsylvania

Status and phase: Completed; Phase 1

Conditions: Cocaine-Related Disorders

Treatments: Drug: Piracetam

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT00000198

K02-00238-3

K20DA000238 (U.S. NIH Grant/Contract)

NIDA-00238-3

Details and patient eligibility

About

The purpose of this study is to evaluate the effects of IV cocaine administration in cocaine dependent subjects maintained on piracetam while they are residing in an inpatient addictions treatment research unit and to subsequently follow these patients in an eight week open label assessment of piracetam in an outpatient treatment program.

Sex: Male

Ages: 21 to 45 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.